13045_2023_1520_MOESM1_ESM.pdf (26.63 MB)
Additional file 1 of Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
journal contribution
posted on 2023-12-17, 04:20 authored by Julie M. Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K. Link, Melissa H. Cessna, Paul M. Barr, Brad S. Kahl, Matthew S. Mckinney, Nadia Khan, Ranjana H. Advani, Peter Martin, Andre H. Goy, Tycel J. Phillips, Amitkumar Mehta, Manali Kamdar, Michael Crump, Barbara Pro, Christopher R. Flowers, Caron A. Jacobson, Sonali M. Smith, Deborah M. Stephens, Veronika Bachanova, Zhaohui Jin, Shishou Wu, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Andrea Anampa-Guzmán, Farshid Kashef, Xing Li, Sunandini Sharma, Timothy C. Greiner, James O. Armitage, Matthew Lunning, Dennis D. Weisenburger, Robert G. Bociek, Javeed Iqbal, Guohua Yu, Chengfeng BiAdditional file 1. Supplementary Table S1 and Supplementary Figures.
Funding
University of Nebraska Foundation
History
Usage metrics
Categories
Keywords
past two decadesp53 positive expressionmantle cell lymphomacurrent multidisciplinary managementcomprehensive retrospective analysissuitable treatment strategiesstudy would servenovel prognostic modelstreatment approachesprognostic modelsline strategiesintegrative analysisclinical managementwide variationvarious applicationsvaluable toolvalidation cohorttraining cohortsubsequent validationstudy aimsstratification resemblingspecifically tailoredrefine prognosticatorspathological parameterspathological featuresmarkedly improvedline therapyinstitutional collaborationindependent cohortimmunochemotherapy eradepth examinationclinicopathological featuresbaseline parametersaccurate prediction
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC